Taken together, these data imply that secretion of eNAMPT, a potent damage-associated molecular pattern and TLR4 ligand, attenuates EDR, which may subsequently lead to the coronary microvascular dysfunction observed in diabetes. This evidence concerns the gene TLR4 and diabetes mellitus.